Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: MLM VMC SUM EXP CRH TTEK OC DY HEI PRIM

| Held by: AVEM VXUS VEU DFEM DFAE IDVO KOMP DFEV BINV DFAX

Index	-	P/E	19.37	EPS (ttm)	0.65	Insider Own	0.00%	Shs Outstand	1.51B	Perf Week	3.03%
Market Cap	19.00B	Forward P/E	14.00	EPS next Y	0.90	Insider Trans	-	Shs Float	1.51B	Perf Month	0.00%
Enterprise Value	24.27B	PEG	0.57	EPS next Q	0.14	Inst Own	35.96%	Short Float	0.78%	Perf Quarter	21.33%
Income	959.41M	P/S	1.17	EPS this Y	22.79%	Inst Trans	-49.73%	Short Ratio	1.74	Perf Half Y	47.88%
Sales	16.24B	P/B	1.37	EPS next Y	10.76%	ROA	1.37%	Short Interest	11.76M	Perf YTD	9.40%
Book/sh	9.19	P/C	10.43	EPS next 5Y	24.73%	ROE	3.14%	52W High	13.35 -5.84%	Perf Year	88.74%
Cash/sh	1.21	P/FCF	18.82	EPS past 3/5Y	20.17% -	ROIC	5.15%	52W Low	4.89 157.06%	Perf 3Y	138.97%
Dividend Est.	0.13 (1.04%)	EV/EBITDA	7.96	Sales past 3/5Y	1.15% 4.73%	Gross Margin	31.36%	Volatility	4.35% 3.48%	Perf 5Y	88.17%
Dividend TTM	0.09 (0.69%)	EV/Sales	1.49	EPS Y/Y TTM	2.61%	Oper. Margin	10.75%	ATR (14)	0.44	Perf 10Y	200.79%
Dividend Ex-Date	Dec 15, 2025	Quick Ratio	0.62	Sales Y/Y TTM	-0.80%	Profit Margin	5.91%	RSI (14)	52.27	Recom	1.90
Dividend Gr. 3/5Y	- -	Current Ratio	0.83	EPS Q/Q	-858.33%	SMA20	-0.69%	Beta	1.60	Target Price	13.66
Payout	13.41%	Debt/Eq	0.51	Sales Q/Q	11.22%	SMA50	4.30%	Rel Volume	1.06	Prev Close	12.27
Employees	39462	LT Debt/Eq	0.40	Earnings	Feb 05 BMO	SMA200	34.68%	Avg Volume	6.75M	Price	12.57
IPO	Sep 15, 1999	Option/Short	Yes / Yes	EPS/Sales Surpr.	-233.48% 3.83%	Trades		Volume	7,126,324	Change	2.44%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-06-26	Downgrade	HSBC Securities	Buy → Hold	$12.80
Dec-08-25	Upgrade	RBC Capital Mkts	Underperform → Sector Perform	$11.25
Oct-21-25	Downgrade	Scotiabank	Sector Outperform → Sector Perform	$11.10
Oct-15-25	Upgrade	BofA Securities	Neutral → Buy
Oct-13-25	Downgrade	Citigroup	Buy → Neutral	$10
Aug-26-25	Upgrade	JP Morgan	Neutral → Overweight	$10.50
Jun-03-25	Downgrade	Itau BBA	Outperform → Market Perform
Mar-26-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Dec-11-24	Downgrade	RBC Capital Mkts	Sector Perform → Underperform	$6 → $5
Oct-29-24	Downgrade	JP Morgan	Overweight → Neutral	$7 → $6
Oct-08-24	Upgrade	RBC Capital Mkts	Underperform → Sector Perform	$9 → $6.50
Aug-21-24	Resumed	JP Morgan	Overweight	$8
Jul-31-24	Upgrade	Barclays	Equal Weight → Overweight	$9
Jul-10-24	Resumed	Goldman	Buy	$9
May-14-24	Initiated	RBC Capital Mkts	Underperform	$9
Apr-24-24	Downgrade	BofA Securities	Buy → Neutral	$9
Feb-09-24	Downgrade	Barclays	Overweight → Equal Weight	$9
Jan-09-24	Upgrade	BofA Securities	Neutral → Buy	$9
Nov-02-23	Resumed	Citigroup	Buy	$8.20
May-15-23	Downgrade	BofA Securities	Buy → Neutral	$6.80 → $7.20

Show Previous Ratings

Feb-10-26 04:39AM	Zacks.com featured highlights include DNOW, FirstSun Capital, Safehold, Amkor and CEMEX (Zacks)
Feb-09-26 08:53AM	5 Value Stocks With Alluring EV-to-EBITDA Ratios to Scoop Up (Zacks)
Feb-06-26 07:06AM	Cemex Q4 Earnings Call Highlights (MarketBeat)
Feb-05-26 04:10PM	Cemex SAB de CV (CX) Q4 2025 Earnings Call Highlights: Strong Cash Flow and Strategic Growth ... (GuruFocus.com)
Feb-03-26 10:15AM	Best Momentum Stocks to Buy for February 3rd (Zacks)
05:47AM	Loading…
05:47AM	New Strong Buy Stocks for February 3rd (Zacks)
03:23AM	Best Value Stocks to Buy for February 3rd (Zacks)
Jan-28-26 12:00PM	Cemex (CX) Is Up 3.36% in One Week: What You Should Know (Zacks)
Jan-26-26 09:40AM	Are Construction Stocks Lagging Cemex (CX) This Year? (Zacks)
Jan-12-26 01:30PM	Cemex Earns Place on CDP 2025 A List for Climate Disclosure Leadership (Business Wire)
12:00PM	Are You Looking for a Top Momentum Pick? Why Cemex (CX) is a Great Choice (Zacks)
Jan-09-26 09:40AM	Is Cemex (CX) Stock Outpacing Its Construction Peers This Year? (Zacks)
Dec-30-25 12:00PM	Cemex (CX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Dec-26-25 11:40AM	CX vs. VMC: Which Stock Should Value Investors Buy Now? (Zacks)
Dec-19-25 12:00PM	Cemex (CX) is a Great Momentum Stock: Should You Buy? (Zacks)
11:40AM	Loading…
Dec-08-25 11:40AM	CX or VMC: Which Is the Better Value Stock Right Now? (Zacks)
Nov-25-25 08:55AM	Fast-paced Momentum Stock Cemex (CX) Is Still Trading at a Bargain (Zacks)
Nov-24-25 09:47AM	CEMEX (CX) Delivers 19% EBITDA Growth in Q3 2025, Analyst Sees Upside (Insider Monkey)
Nov-21-25 11:40AM	CX or VMC: Which Is the Better Value Stock Right Now? (Zacks)
Nov-18-25 11:15AM	Cemex US Appoints Will Price as Senior Vice President of Mergers & Acquisitions (Business Wire)
Nov-06-25 12:00PM	Cemex (CX) Is Up 8.44% in One Week: What You Should Know (Zacks)
Nov-04-25 12:00PM	What Makes Cemex (CX) a New Buy Stock (Zacks)
11:40AM	CX vs. MLM: Which Stock Is the Better Value Option? (Zacks)
Oct-30-25 03:20PM	Cemex SAB de CV (CX) Q3 2025 Earnings Call Highlights: Record EBITDA Margins and Strategic ... (GuruFocus.com)
Oct-27-25 09:18AM	Earnings To Watch: Cemex SAB de CV (MEX:CEMEXCPO) Reports Q3 2025 Result (GuruFocus.com)
Oct-24-25 07:42AM	Cemex S.A.B. de C.V. (CX) Gets Downgraded to Sector Perform from Outperform by Scotiabank (Insider Monkey)
Oct-15-25 11:13AM	Home Builder Stocks Rally. Charts of Pulte, CRH, Cemex Point to Further Upside (Barrons.com)
Sep-15-25 09:03AM	BofA Securities Lifts CEMEX, S.A.B. de C.V. (CX) Price Target on Capital Return Plans (Insider Monkey)
Sep-04-25 08:41AM	Cemex price target raised to $10 from $8.60 at BofA (TipRanks)
Aug-26-25 09:57AM	JPMorgan sees 15% average upside for U.S. construction materials stocks (Investing.com)
09:23AM	Loading…
Aug-18-25 09:23AM	SaverOne Broadens its Relationship with Cemex: An Additional European Cemex Division Deploys SaverOnes Driver Distraction Prevention System (GlobeNewswire)
Aug-12-25 09:41AM	CEMEX, S.A.B. de C.V.'s (CX) Net Income up 33% on Robust Cement Volume Growth (Insider Monkey)
Jul-25-25 03:19AM	Cemex SAB de CV (CX) Q2 2025 Earnings Call Highlights: Strong Net Income Growth and Strategic ... (GuruFocus.com)
Jul-23-25 09:20AM	What To Expect From Cemex SAB de CV (MEX:CEMEXCPO) Q2 2025 Earnings (GuruFocus.com)
May-27-25 01:04PM	Barclays Maintains Buy Rating on CEMEX (CX) Stock (Insider Monkey)
May-09-25 07:56AM	CEMEX, S.A.B. de C.V. (CX): Among Billionaire Rob Citrone's Small-Cap Stock Picks with Huge Upside Potential (Insider Monkey)
May-05-25 07:29AM	The Housing Market is In Trouble - What to Watch Out For (MarketBeat)
Apr-29-25 03:03AM	Cemex SAB de CV (CX) Q1 2025 Earnings Call Highlights: Record Net Income and Strategic ... (GuruFocus.com)
01:01AM	Why CEMEX, S.A.B. de C.V. (CX) Surged on Monday (Insider Monkey)
Apr-28-25 02:57PM	CEMEX, S.A.B. de C.V. (CX) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:18AM	Shares in Mexico's Cemex's jump as Dominican asset sale propels profit (Reuters)
Apr-26-25 04:43AM	Why CEMEX, S.A.B. de C.V. (CX) Went Up On Friday (Insider Monkey)
Apr-02-25 08:30AM	Cautious Optimism for Building Products Distribution Rising as Sustained Demand for New Residential Construction Expected (GlobeNewswire)
Apr-01-25 07:30AM	Jaime Muguiro Begins Tenure as CEO of Cemex (Business Wire)
Mar-27-25 09:45AM	Wingstop initiated, CarMax upgraded: Wall Streets top analyst calls (TipRanks)
Mar-26-25 07:31AM	Why Cemex SAB de CV (CX) Went Up On Tuesday? (InsiderMonkey)
Mar-25-25 06:27PM	Cemex showcases significant operational and sustainability advancements in its 2024 Integrated Report (Business Wire)
Mar-24-25 08:35AM	FPA Queens Road Small Cap Value Fund Q4 2024 Commentary (SeekingAlpha)
Mar-11-25 07:00AM	Cemex Recognized as One of the World's Most Ethical Companies (Business Wire)
Mar-03-25 04:30PM	Cemex celebrates 25 years of biodiversity conservation and restoration at El Carmen Nature Reserve (Business Wire)
Feb-28-25 05:06PM	Is CEMEX, S.A.B. de C.V. (CX) the Best Construction Stock to Buy Now? (Insider Monkey)
Feb-24-25 02:08PM	Cemex Explores Sale of Colombian Cement Business (Bloomberg)
Feb-10-25 07:17AM	Cemex Announces Senior Level Organizational Changes (Business Wire)
06:40AM	Cemex Announces CEO Transition (Business Wire)
Feb-07-25 02:16AM	Cemex SAB de CV (CX) Q4 2024 Earnings Call Highlights: Record Net Income and Strategic ... (GuruFocus.com)
12:16AM	Why Cemex SAB de CV (CX) Advanced on Thursday (Insider Monkey)
Feb-06-25 11:04AM	Cemex Shares Rise as It Sees Recovery in US Cement Demand (Bloomberg) +13.38%
Jan-27-25 05:42AM	Following sharp downturn, contech funding stabilizes (Construction Dive)
Dec-18-24 07:00AM	Teamsters have some legal issues to overcome after wins at Amazon and with DSPs (FreightWaves)
Dec-11-24 06:18AM	Cemex stock downgraded amid US-Mexico trade risks (Investing.com)
Dec-10-24 05:03AM	Cemex supports $865m Howard Frankland bridge construction in Florida (World Construction Network)
Dec-03-24 06:31AM	Cemex SAB Completes $800 Million Philippines Exit (TipRanks)
Nov-29-24 03:08AM	Why CEMEX, S.A.B. de C.V. (CX) Is One of the Best Construction Materials Stocks to Buy Now? (Insider Monkey)
Nov-20-24 06:29PM	Cemex Recognized at COP29 for Solar Clinker Breakthrough (Business Wire)
Nov-02-24 06:00AM	After a century, concrete plant that helped build L.A. makes way for a deluxe tower (LA Times)
Oct-29-24 03:03AM	Cemex SAB de CV (CX) Q3 2024 Earnings Call Highlights: Record Net Income Growth Amid Weather ... (GuruFocus.com)
Oct-28-24 10:39AM	Cemex Falls Most Since 2020 on Earnings Miss, Lower Outlook (Bloomberg) -8.70%
Oct-23-24 10:10AM	Contech startup contest taps 8 finalists (Construction Dive)
Oct-22-24 04:16PM	EU Backs Pioneering CO2 Capture Project at Cemexs Rüdersdorf Cement Plant (Business Wire)
Oct-20-24 06:59PM	Is CEMEX (CX) the Best Affordable Stock Under $10 to Buy? (Insider Monkey)
Oct-14-24 11:36AM	CEMEX, S.A.B. de C.V. (CX): Leader in Best Cement and Construction Materials Stock (Insider Monkey)
08:44AM	Is Cemex (CX) The Best Undervalued Building Materials Stock to Buy Now? (Insider Monkey)
Sep-26-24 09:08PM	Is CEMEX, S.A.B. de C.V. (CX) the Best Construction Stock To Buy According to Analysts? (Insider Monkey)
Sep-25-24 03:23PM	Fortune Recognizes Cemex for the Fourth Time as a Company That Is Changing the World (Business Wire)
Sep-23-24 10:34PM	CEMEX, S.A.B. de C.V. (CX): Among the Worst Affordable Stocks to Buy Under $10 (Insider Monkey)
Sep-03-24 06:00PM	Cemex expands Regenera circularity business with acquisition in Berlin (Business Wire)
Aug-23-24 09:23AM	Cemex supplies Vertua concrete for US urban development (World Construction Network)
Aug-05-24 06:39AM	Cemex to divest Dominican operations for $950 million (Reuters)
Jul-20-24 03:00PM	3 Hidden Gem Stocks Ready to Explode in July (InvestorPlace)
Jul-18-24 05:00AM	Cemex Partners With the Ellen MacArthur Foundation to Accelerate Circular Economy Efforts in the Built Environment (Business Wire)
Jul-09-24 10:17AM	Werner battling unions on 2 fronts; 1 fight may have broader significance (FreightWaves)
Jul-08-24 06:00AM	Emerging Markets Spotlight: 7 Hidden Gems Set to Explode (InvestorPlace)
Jun-26-24 04:36AM	Mondi and Cemex launch SolmixBag solution in Balearic Islands (Packaging Gateway)
Jun-10-24 07:30AM	Fast Movers: 3 Stocks to Catch Before They Soar (InvestorPlace)
May-20-24 08:30AM	3 Low-Visibility Stocks With High Potential Returns (InvestorPlace)
May-13-24 11:25AM	Cemex and MPP collaborate to accelerate decarbonization projects (PR Newswire)
May-09-24 06:37PM	25 Largest Companies in Mexico by Revenue (Insider Monkey)
May-07-24 06:32PM	Cemex Tops Industry in 2024 Climate and Energy Benchmark (Business Wire)
Apr-30-24 05:42PM	Fitch Ratings Upgrades Cemex to Investment Grade (Business Wire)
08:51AM	CEMEX, S.A.B. de C.V. (NYSE:CX) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-29-24 10:02AM	13 Best Growth Stocks Under $10 to Buy (Insider Monkey)
Apr-28-24 09:10PM	10 Best Construction Materials Stocks To Invest In Right Now (Insider Monkey)
Mar-13-24 07:03PM	Standard & Poors Upgrades Cemex to Investment Grade (Business Wire)
Mar-09-24 12:45PM	Citrone's Top 15 Stock Picks (Insider Monkey)
Dec-05-23 05:20PM	Cemex Unveiled the First Fully Electric Ready-Mix Truck in the Middle East During COP28 in Dubai (Business Wire)
Dec-04-23 08:14AM	Cemex passes 1,000 lower-carbon truck milestone (Business Wire)
Oct-27-23 10:39AM	CEMEX, S.A.B. de C.V. (NYSE:CX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-24-23 08:30AM	Tallest tower in Latin America built with Cemexs Vertua lower-carbon concrete (Business Wire)
Oct-16-23 08:00AM	Fernando A. González, CEO of Cemex, elected President of the Global Cement and Concrete Association (Business Wire)
Sep-06-23 08:30AM	SaverOne Expand its Cooperation with Cemex: Launches First European Pilot with Cemex in Spain (PR Newswire)

CEMEX SAB de CV operates as a global construction materials company. It offers cement, ready-mixconcrete, aggregates, and urbanization solutions. The firm operates through the following geographical segments: Mexico, United States, Europe, Middle East, Africa and Asia (EMEAA) and South, Central America and the Caribbean (SCA&C). The company was founded by Lorenzo Zambrano Gutierrez in 1906 and is headquartered in San Pedro Garza Garcia, Mexico.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
JESUS VICENTE GONZALEZ HERRERA	Officer	Nov 07 '25	Proposed Sale	10.22	40,000	408,904	Nov 07 04:21 PM
Rodriguez Louisa	Officer	Oct 31 '25	Proposed Sale	10.27	38,125	391,734	Oct 31 09:52 AM
JESUS VICENTE GONZALEZ HERRERA	Officer	Aug 05 '25	Proposed Sale	8.26	45,000	371,588	Aug 05 04:15 PM
ROGER SALDANA MADERO	Officer	Jul 29 '25	Proposed Sale	8.61	50,011	430,470	Jul 29 04:02 PM

Open in Screener

DYN

Dyne Therapeutics Inc

Feb 13 • 04:00PM ET

15.54

-0.46 -2.88 %

Healthcare • Biotechnology • USA • NASD

DYN Dyne Therapeutics Inc daily Stock Chart

Peers: BIIB VRTX CRSP ALNY BMRN RARE NTLA SRPT EDIT BLUE

| Held by: VTI XBI IWM VB VXF VBR IBB VTWO IWN SCHA

Index	RUT	P/E	-	EPS (ttm)	-3.66	Insider Own	26.51%	Shs Outstand	142.61M	Perf Week	-7.50%
Market Cap	2.51B	Forward P/E	-	EPS next Y	-3.25	Insider Trans	-0.03%	Shs Float	118.92M	Perf Month	-10.95%
Enterprise Value	1.84B	PEG	-	EPS next Q	-0.76	Inst Own	87.99%	Short Float	16.14%	Perf Quarter	-16.50%
Income	-423.80M	P/S	-	EPS this Y	-3.91%	Inst Trans	51.09%	Short Ratio	7.70	Perf Half Y	24.32%
Sales	0.00M	P/B	3.20	EPS next Y	7.20%	ROA	-51.81%	Short Interest	19.19M	Perf YTD	-20.55%
Book/sh	4.85	P/C	3.18	EPS next 5Y	4.87%	ROE	-60.66%	52W High	25.00 -37.84%	Perf Year	10.60%
Cash/sh	4.89	P/FCF	-	EPS past 3/5Y	-4.75% -59.45%	ROIC	-52.50%	52W Low	6.36 144.34%	Perf 3Y	16.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.57% 5.92%	Perf 5Y	-16.50%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-2.75%	Oper. Margin	-	ATR (14)	1.04	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	13.47	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	34.23	Recom	1.31
Dividend Gr. 3/5Y	- -	Current Ratio	13.47	EPS Q/Q	20.87%	SMA20	-10.70%	Beta	1.34	Target Price	39.12
Payout	-	Debt/Eq	0.17	Sales Q/Q	-	SMA50	-15.82%	Rel Volume	0.36	Prev Close	16.00
Employees	191	LT Debt/Eq	0.17	Earnings	Nov 05 AMC	SMA200	4.58%	Avg Volume	2.49M	Price	15.54
IPO	Sep 17, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.21% -	Trades		Volume	898,857	Change	-2.88%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-25	Upgrade	Oppenheimer	Perform → Outperform	$40
Oct-10-25	Downgrade	Oppenheimer	Outperform → Perform
Aug-25-25	Upgrade	Raymond James	Outperform → Strong Buy	$35
Jun-24-25	Initiated	Bernstein	Mkt Perform	$13
Jun-11-25	Resumed	Raymond James	Outperform	$37
Jun-02-25	Resumed	Oppenheimer	Outperform	$34
May-29-25	Initiated	Evercore ISI	Outperform	$46
Mar-12-25	Initiated	BMO Capital Markets	Outperform	$50
Mar-07-25	Initiated	Scotiabank	Sector Outperform	$50
Dec-13-24	Initiated	Robert W. Baird	Outperform	$46
Nov-26-24	Initiated	RBC Capital Mkts	Outperform	$45
Oct-24-24	Downgrade	JP Morgan	Overweight → Neutral	$43 → $35
May-21-24	Reiterated	Chardan Capital Markets	Buy	$31 → $42
Apr-30-24	Initiated	Morgan Stanley	Overweight	$40
Feb-20-24	Initiated	H.C. Wainwright	Buy	$36
Feb-27-23	Upgrade	Raymond James	Outperform → Strong Buy	$16 → $27
Feb-15-23	Initiated	Oppenheimer	Outperform	$34
Jan-26-23	Initiated	Guggenheim	Buy	$33
Jul-20-22	Initiated	Chardan Capital Markets	Buy	$17
Jul-12-22	Initiated	Raymond James	Outperform	$15

Show Previous Ratings

Jan-27-26 09:16AM	Keros Therapeutics vs. Dyne: Which DMD Biotech Has More Upside? (Zacks)
Jan-20-26 07:30AM	Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (GlobeNewswire)
Jan-15-26 11:35AM	Analysts Project 120% Upside To Dyne Therapeutics, Inc. (DYN) (Insider Monkey) -5.90%
Jan-12-26 12:00PM	Funding for Risky Biotechs Is Returning (The Wall Street Journal)
Jan-07-26 07:30AM	Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +7.01%
07:30AM	Loading…
Dec-23-25 07:30AM	Dyne Therapeutics Appoints Vikram Karnani to Board of Directors (GlobeNewswire)
Dec-22-25 06:50AM	Why Analysts See a Huge Upside for Dyne Therapeutics (DYN) (Insider Monkey)
Dec-11-25 04:05PM	Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares (GlobeNewswire)
07:44AM	Dyne Therapeutics Shares Rise After Announcing Positive Topline Results for z-rostudirsen in Phase 1/2 DMD Trial (Insider Monkey)
Dec-10-25 06:20PM	Why Dyne Therapeutics Stock Was a Big Winner on Wednesday (Motley Fool) +6.78%
09:40AM	Amazon initiated, GE Vernova upgraded: Wall Street's top analyst calls (The Fly)
Dec-09-25 09:42PM	Dyne Therapeutics Announces Pricing of Upsized $350.0 Million Public Offering of Common Stock (GlobeNewswire) -16.94%
06:42PM	Why Dyne Therapeutics Stock Tanked on Tuesday (Motley Fool)
04:54PM	Biggest Market Movers Today, Dec. 9: WRBY, DYN, & More (Motley Fool)
02:22PM	Dyne Therapeutics (DYN) Climbs 9.5% on Stellar Results for DMD Therapy Candidate (Insider Monkey)
01:34PM	Loading…
01:34PM	Dyne to seek accelerated approval of DMD drug on Phase I/II data (Clinical Trials Arena)
Dec-08-25 04:02PM	Dyne Therapeutics Announces Proposed Public Offering of Common Stock (GlobeNewswire) +9.47%
03:07PM	Why Dyne Therapeutics Stock Was Blasting Higher Today (Motley Fool)
06:30AM	Dyne Therapeutics Announces Positive Topline Results from Phase 1/2 DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) (GlobeNewswire)
05:32AM	Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar (BioPharma Dive)
Dec-07-25 11:00AM	Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:00 a.m. ET (GlobeNewswire)
Nov-30-25 12:26AM	Bernstein Sees Favorable Risk-Reward for Dyne Therapeutics (DYN) Ahead of Major DYN-251 Data Release (Insider Monkey)
Nov-21-25 03:43PM	Why Dyne Therapeutics Stock Was Crushing it This Week (Motley Fool) +5.27%
Nov-05-25 04:10PM	Dyne Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights (GlobeNewswire) -12.89%
Nov-03-25 07:30AM	Dyne Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire) +6.78%
Oct-28-25 05:24AM	Dyne (DYN) Jumps 41% as Jefferies Bets Firm to Benefit from Novartis-Avidity Merger (Insider Monkey)
Oct-27-25 06:17PM	Why Dyne Therapeutics Stock Crushed the Market on Monday (Motley Fool) +41.18%
04:54PM	This biotech's stock soared as investors look for the next buyout target (MarketWatch)
12:07PM	Why Avidity Biosciences And Dyne Therapeutics Stocks Soared 40% Monday (Investopedia)
05:26AM	Dyne, Avidity stocks soar as Novartis strikes $12 bln biotech deal (Investing.com)
04:39AM	Loading…
04:39AM	Jefferies sees Dyne as key beneficiary of Novartis Avidity buyout (Investing.com)
Oct-16-25 04:33PM	Dyne's Zeleciment Basivarsen Shows Sustained Gains in DM1 Trial at One Year (Insider Monkey)
Oct-06-25 06:01PM	Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) (GlobeNewswire) +10.28%
Oct-04-25 04:54PM	Dyne's Investigational DMD Drug DYNE-251 Gets Japan Orphan Drug Status After Strong Trial Data (Insider Monkey)
Oct-02-25 04:05PM	Dyne Therapeutics Appoints Brian Posner to its Board of Directors (GlobeNewswire)
Sep-29-25 08:35AM	Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy (GlobeNewswire) -5.93%
Sep-10-25 12:20AM	Raymond James Increases PT on Dyne Therapeutics Stock from $31 to $35, Maintains Buy Rating (Insider Monkey)
Aug-27-25 07:30AM	Dyne Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-20-25 12:13AM	Morgan Stanley Reiterates a Buy Rating on Dyne Therapeutics (DYN), Keeps the PT (Insider Monkey)
Aug-17-25 11:41PM	Dyne Therapeutics Receives FDA Breakthrough Therapy Designation for Duchenne Muscular Dystrophy Therapy (Insider Monkey)
Aug-06-25 12:00PM	Avidity Biosciences stock soars on Novartis takeover approach report (Investing.com) +10.70%
Aug-04-25 07:30AM	Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD) (GlobeNewswire)
Jul-31-25 09:55AM	Does Dyne Therapeutics (DYN) Have the Potential to Rally 285.57% as Wall Street Analysts Expect? (Zacks)
Jul-28-25 04:10PM	Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights (GlobeNewswire) -6.43%
Jul-16-25 07:00AM	Satellos Appoints Dr. Wildon Farwell as Chief Medical Officer (Business Wire) +12.68%
Jul-11-25 11:27AM	RBC Capital Maintains a Buy Rating on Dyne Therapeutics (DYN) With a $25 PT (Insider Monkey)
Jul-02-25 04:01PM	Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares (GlobeNewswire)
Jun-30-25 09:45PM	Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock (GlobeNewswire) -8.82%
04:05PM	Dyne Therapeutics Announces Proposed Public Offering of Common Stock (GlobeNewswire)
04:01PM	Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital (GlobeNewswire)
Jun-24-25 12:46PM	Dyne Therapeutics Receives FDA Breakthrough Therapy Designation for DM1 Drug DYNE-101 (Insider Monkey)
Jun-18-25 09:45AM	Dyne at attractive entry point following pullback, says Chardan (TipRanks)
Jun-17-25 07:00AM	Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting (GlobeNewswire) -21.42%
Jun-16-25 04:05PM	Dyne Therapeutics to Host Investor Conference Call and Webcast to Provide Update on DYNE-101 for Myotonic Dystrophy Type 1, Tomorrow Tuesday, June 17 at 8:00 a.m. ET (GlobeNewswire)
Jun-05-25 07:30AM	Dyne Therapeutics to Present New Preclinical Data in Facioscapulohumeral Muscular Dystrophy at the FSHD Society International Research Congress (GlobeNewswire)
May-08-25 07:30AM	Dyne Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights (GlobeNewswire) +20.16%
Apr-25-25 05:05AM	EC grants orphan drug designation to Dyne Therapeutics DMD therapy (Pharmaceutical Technology)
Apr-24-25 07:30AM	Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy (GlobeNewswire)
Apr-21-25 04:09PM	Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost (Investor's Business Daily) +14.20% +6.22%
Apr-15-25 07:30AM	Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments (GlobeNewswire) +5.09%
Apr-14-25 04:30PM	Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +6.11%
Apr-01-25 11:50AM	Biotech stocks slide as Marks resignation seen being negative for sector (TipRanks) -11.76%
Mar-30-25 03:50AM	abrdn Life Sciences Investors Q4 2024 Commentary (Seeking Alpha)
Mar-28-25 09:00AM	RNA Biotechs: Current State And Outlook (Seeking Alpha)
Mar-20-25 04:30PM	Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Financial Officer (GlobeNewswire)
04:19PM	Dyne Therapeutics appoints Erick Lucera as CFO (SeekingAlpha)
04:10PM	Dyne Therapeutics Announces Appointment of Erick J. Lucera as Chief Financial Officer (GlobeNewswire)
Mar-16-25 07:00PM	Dyne Therapeutics Announces New Long-Term Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented and Sustained Functional Improvement Through 18 Months (GlobeNewswire)
Mar-12-25 03:05PM	Dyne Therapeutics' $4.3 Billion Peak Sales Potential? Analyst Highlights Key Strengths And Risks (Benzinga)
01:12PM	BMO Capital Initiates Coverage on Dyne Therapeutics With Outperform Rating (GuruFocus.com)
Mar-11-25 07:30AM	Dyne Therapeutics to Present at Stifel 2025 Virtual CNS Forum (GlobeNewswire)
Feb-27-25 07:30AM	Dyne Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights (GlobeNewswire)
Feb-14-25 04:05PM	Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical & Scientific Conference (GlobeNewswire)
Feb-13-25 09:35AM	After Plunging -10.43% in 4 Weeks, Here's Why the Trend Might Reverse for Dyne Therapeutics (DYN) (Zacks)
Feb-06-25 09:39AM	Dyne Therapeutics, Inc. (DYN): Among the Best Rebound Stocks to Invest In Now (Insider Monkey) +6.89%
Feb-03-25 07:30AM	Dyne Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Jan-28-25 09:35AM	Down -42.2% in 4 Weeks, Here's Why Dyne Therapeutics (DYN) Looks Ripe for a Turnaround (Zacks)
Jan-21-25 07:30AM	Dyne Therapeutics Receives FDA Fast Track Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1 (GlobeNewswire)
Jan-10-25 06:30AM	Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101 in DM1 in H1 2026 (GlobeNewswire) -31.15%
Jan-09-25 07:30AM	Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-08-25 04:05PM	Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET (GlobeNewswire) -31.15%
Nov-22-24 06:43AM	Dyne Therapeutics Inc. (DYN): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts (Insider Monkey)
Nov-12-24 07:30AM	Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-07-24 04:15PM	Dyne Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
Oct-09-24 07:30AM	Dyne Therapeutics Presents Data at World Muscle Society Congress Highlighting Promise of FORCE Platform to Address Underlying Causes of Neuromuscular Diseases (GlobeNewswire)
Oct-07-24 05:32PM	Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now (Insider Monkey)
Sep-23-24 08:56AM	Dyne Therapeutics to Present at Chardan's 8th Annual Genetic Medicines Conference (GlobeNewswire) -5.36%
Sep-04-24 09:10AM	Dyne Called Its Sarepta-Rivaling Results 'Unprecedented,' But Shares Dive On C-Suite Changes (Investor's Business Daily) +5.70%
08:15AM	High-dose Spinraza meets study goal; Top Dyne executives exit (BioPharma Dive)
Sep-03-24 12:37PM	Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy (Benzinga) -30.70%
06:31AM	Dyne Therapeutics Announces Key Leadership Appointments (GlobeNewswire)
06:30AM	Dyne Therapeutics Announces New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented Dystrophin Expression and Functional Improvement in Multiple Cohorts (GlobeNewswire)
Aug-29-24 07:30AM	Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-12-24 10:52PM	DYN Stock Earnings: Dyne Therapeutics Beats EPS for Q2 2024 (InvestorPlace)
05:10PM	Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights (GlobeNewswire)
Jul-29-24 08:50AM	Recent Price Trend in Dyne Therapeutics (DYN) is Your Friend, Here's Why (Zacks)
Jul-18-24 12:00PM	What Makes Dyne Therapeutics, Inc. (DYN) a Strong Momentum Stock: Buy Now? (Zacks)
Jul-12-24 08:50AM	Dyne Therapeutics (DYN) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Jun-24-24 07:30AM	Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease (GlobeNewswire)
Jun-13-24 04:40PM	Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress (GlobeNewswire)

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kerr Douglas	Officer	Dec 05 '25	Proposed Sale	20.72	880	18,231		Dec 05 04:56 PM
Cox John	Officer	Dec 05 '25	Proposed Sale	20.72	2,662	55,150		Dec 05 04:55 PM
Cox John	CEO & President	Dec 05 '25	Sale	20.72	2,662	55,157	196,877	Dec 05 04:11 PM
Kerr Douglas	Chief Medical Officer	Dec 05 '25	Sale	20.72	880	18,234	87,510	Dec 05 04:09 PM
Friedl-Naderer Johanna	Chief Commercial Officer	Dec 05 '25	Sale	20.72	144	2,984	94,729	Dec 05 04:08 PM
Cox John	CEO & President	Sep 05 '25	Sale	13.41	2,640	35,402	199,539	Sep 09 04:31 PM
Friedl-Naderer Johanna	Chief Commercial Officer	Sep 04 '25	Sale	13.27	894	11,863	95,017	Sep 08 04:06 PM
Friedl-Naderer Johanna	Chief Commercial Officer	Sep 05 '25	Sale	13.41	144	1,931	94,873	Sep 08 04:06 PM
Kerr Douglas	Chief Medical Officer	Sep 04 '25	Sale	13.27	3,552	47,135	89,263	Sep 08 04:03 PM
Kerr Douglas	Chief Medical Officer	Sep 05 '25	Sale	13.41	873	11,707	88,390	Sep 08 04:03 PM
Cox John	Officer	Sep 05 '25	Proposed Sale	13.41	2,640	35,404		Sep 05 04:14 PM
Kerr Douglas	Officer	Sep 04 '25	Proposed Sale	13.27	4,552	60,402		Sep 04 04:45 PM
Cox John	CEO & President	Jul 14 '25	Buy	9.11	100,000	911,000	242,179	Jul 15 05:11 PM
Scalzo Richard William	Officer	Jun 11 '25	Proposed Sale	14.75	1,330	19,619		Jun 11 04:30 PM
Beskrovnaya Oxana	Officer	Jun 11 '25	Proposed Sale	14.75	2,132	31,449		Jun 11 04:29 PM
Cox John	CEO & President	Jun 05 '25	Sale	13.35	4,060	54,201	142,179	Jun 06 04:07 PM
Kerr Douglas	Chief Medical Officer	Jun 05 '25	Sale	13.35	1,342	17,916	92,815	Jun 06 04:05 PM
Friedl-Naderer Johanna	Chief Commercial Officer	Jun 05 '25	Sale	13.35	146	1,949	95,911	Jun 06 04:03 PM
Kerr Douglas	Officer	Jun 05 '25	Proposed Sale	13.35	1,342	17,911		Jun 05 04:13 PM
Cox John	Officer	Jun 05 '25	Proposed Sale	13.35	4,060	54,186		Jun 05 04:11 PM
Scalzo Richard William	Officer	Jun 05 '25	Proposed Sale	13.35	914	12,198		Jun 05 04:09 PM
Beskrovnaya Oxana	Officer	Jun 05 '25	Proposed Sale	13.35	1,093	14,587		Jun 05 04:07 PM
Scalzo Richard William	Officer	May 16 '25	Proposed Sale	11.82	2,479	29,313		May 16 04:10 PM
Beskrovnaya Oxana	Officer	May 16 '25	Proposed Sale	11.82	2,589	30,614		May 16 04:09 PM
Friedl-Naderer Johanna	Chief Commercial Officer	Mar 13 '25	Sale	12.12	143	1,733	96,057	Mar 13 04:13 PM
Scalzo Richard William	SVP, Head of Finance & Admin.	Mar 11 '25	Sale	11.38	1,343	15,283	122,330	Mar 13 04:08 PM
Beskrovnaya Oxana	Chief Scientific Officer	Mar 11 '25	Sale	11.38	2,153	24,501	195,840	Mar 13 04:08 PM
Beskrovnaya Oxana	Officer	Mar 11 '25	Proposed Sale	11.38	2,153	24,493		Mar 11 04:09 PM
Scalzo Richard William	Officer	Mar 11 '25	Proposed Sale	11.38	1,343	15,278		Mar 11 04:08 PM
Kerr Douglas	Chief Medical Officer	Mar 05 '25	Sale	11.83	1,343	15,888	94,157	Mar 07 04:08 PM
Cox John	CEO & President	Mar 05 '25	Sale	11.83	4,061	48,042	146,239	Mar 07 04:07 PM
Scalzo Richard William	SVP, Head of Finance & Admin.	Mar 05 '25	Sale	11.83	917	10,848	123,673	Mar 07 04:06 PM
Beskrovnaya Oxana	Chief Scientific Officer	Mar 05 '25	Sale	11.83	1,094	12,942	197,993	Mar 07 04:04 PM
Kerr Douglas	Officer	Mar 05 '25	Proposed Sale	11.89	1,343	15,968		Mar 05 04:10 PM
Cox John	Officer	Mar 05 '25	Proposed Sale	11.89	4,067	48,356		Mar 05 04:09 PM
Beskrovnaya Oxana	Officer	Mar 05 '25	Proposed Sale	11.89	1,094	13,007		Mar 05 04:08 PM
Scalzo Richard William	Officer	Mar 05 '25	Proposed Sale	11.89	915	10,879		Mar 05 04:07 PM
Beskrovnaya Oxana	Chief Scientific Officer	Feb 18 '25	Sale	13.95	2,598	36,242	199,087	Feb 25 05:09 PM
Scalzo Richard William	SVP, Head of Finance & Admin.	Feb 18 '25	Sale	13.95	2,488	34,708	124,590	Feb 18 05:09 PM
Scalzo Richard William	Officer	Feb 18 '25	Proposed Sale	13.91	2,488	34,608		Feb 18 04:15 PM
Beskrovnaya Oxana	Officer	Feb 18 '25	Proposed Sale	13.91	2,598	36,138		Feb 18 04:14 PM

Open in Screener

KOS

Kosmos Energy Ltd

Feb 13 • 04:00PM ET

1.68

+0.06 3.70 %

Energy • Oil & Gas E&P • USA • NYSE

Peers: XOM HES CVX COP OXY APA DVN EOG MPC MUR

| Held by: IWM XOP FNDA FCG IWN VXF FYX SCHA VDE PRFZ

Index	RUT	P/E	-	EPS (ttm)	-0.69	Insider Own	4.11%	Shs Outstand	478.25M	Perf Week	13.51%
Market Cap	803.59M	Forward P/E	-	EPS next Y	-0.16	Insider Trans	-1.37%	Shs Float	458.69M	Perf Month	32.28%
Enterprise Value	3.72B	PEG	-	EPS next Q	-0.12	Inst Own	82.51%	Short Float	10.95%	Perf Quarter	15.86%
Income	-329.22M	P/S	0.57	EPS this Y	-243.37%	Inst Trans	-1.57%	Short Ratio	2.93	Perf Half Y	-3.45%
Sales	1.40B	P/B	0.89	EPS next Y	73.74%	ROA	-6.23%	Short Interest	50.24M	Perf YTD	85.14%
Book/sh	1.88	P/C	12.55	EPS next 5Y	-	ROE	-31.42%	52W High	3.49 -51.86%	Perf Year	-45.81%
Cash/sh	0.13	P/FCF	-	EPS past 3/5Y	- -	ROIC	-9.08%	52W Low	0.84 100.93%	Perf 3Y	-79.10%
Dividend Est.	-	EV/EBITDA	7.82	Sales past 3/5Y	7.85% 2.32%	Gross Margin	-1.28%	Volatility	10.34% 9.71%	Perf 5Y	-41.67%
Dividend TTM	-	EV/Sales	2.66	EPS Y/Y TTM	-248.33%	Oper. Margin	-7.24%	ATR (14)	0.15	Perf 10Y	-57.89%
Dividend Ex-Date	Mar 04, 2020	Quick Ratio	0.29	Sales Y/Y TTM	-22.11%	Profit Margin	-23.52%	RSI (14)	60.16	Recom	2.27
Dividend Gr. 3/5Y	- -	Current Ratio	0.52	EPS Q/Q	-377.08%	SMA20	15.35%	Beta	0.84	Target Price	2.40
Payout	0.00%	Debt/Eq	3.31	Sales Q/Q	-24.38%	SMA50	41.79%	Rel Volume	0.82	Prev Close	1.62
Employees	243	LT Debt/Eq	3.04	Earnings	Mar 02 BMO	SMA200	4.77%	Avg Volume	17.13M	Price	1.68
IPO	May 11, 2011	Option/Short	Yes / Yes	EPS/Sales Surpr.	-21.85% -9.34%	Trades		Volume	13,990,521	Change	3.70%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-05-25	Downgrade	Johnson Rice	Buy → Accumulate	$3.50
Dec-05-25	Downgrade	BofA Securities	Buy → Underperform	$1
Nov-11-25	Initiated	Stephens	Equal-Weight	$1.75
Oct-24-25	Initiated	Clarksons Platou	Buy	$4
Sep-22-25	Downgrade	Goldman	Buy → Neutral	$2
Mar-04-25	Downgrade	The Benchmark Company	Buy → Hold
Dec-18-24	Resumed	Jefferies	Buy	$5.60
Sep-19-24	Initiated	Mizuho	Neutral	$5
Nov-20-23	Initiated	Stifel	Buy	$10
Oct-17-23	Downgrade	Bernstein	Outperform → Mkt Perform	$12 → $9
Sep-27-23	Upgrade	BofA Securities	Neutral → Buy	$8.70 → $10
Jul-20-23	Initiated	Redburn	Buy	$9
Mar-10-23	Initiated	Peel Hunt	Add	$8.94
Feb-28-23	Downgrade	BofA Securities	Buy → Neutral	$10 → $9.60
Feb-09-23	Initiated	The Benchmark Company	Buy	$10
Aug-25-22	Upgrade	Berenberg	Hold → Buy	$8.30 → $8.50
Jun-13-22	Downgrade	Berenberg	Buy → Hold
Nov-11-21	Upgrade	Barclays	Equal Weight → Overweight	$3.95
Oct-15-21	Upgrade	Berenberg	Hold → Buy
Jun-21-21	Upgrade	Bernstein	Mkt Perform → Outperform

Show Previous Ratings

Feb-02-26 02:00AM	Kosmos Energy to Host Fourth Quarter 2025 Results and Webcast on March2, 2026 (Business Wire) -13.92%
Jan-17-26 12:09AM	Kosmos Energy (KOS) Shot Up This Week. Here is Why (Insider Monkey)
Jan-16-26 10:05AM	Kosmos Energy Announces Pricing of Nordic Bond Issue (Business Wire)
Jan-12-26 04:23AM	Kosmos Energy (KOS) Shares Operational Update, Bernstein Remains Bullish (Insider Monkey) +10.35%
02:00AM	Kosmos Energy Announces Launch of Nordic Bond Issue and Cash Tender Offer for 7.750% Senior Notes Due 2027 (Business Wire)
12:12AM	Loading…
Jan-08-26 12:12AM	Kosmos Energy (KOS) Gains Following Significant Progress in West Africa (Insider Monkey)
Jan-05-26 02:00AM	Kosmos Energy Provides Operational and Financial Update (Business Wire) +10.89%
Dec-20-25 06:47AM	Kosmos Energy (KOS) Price Targets Trimmed by Analysts (Insider Monkey)
Dec-09-25 11:49AM	Kosmos Energy (KOS) Misses Q3 Estimates, Analysts Split on Outlook (Insider Monkey)
Dec-05-25 09:42AM	CoreWeave initiated, Unity upgraded: Wall Street's top analyst calls (The Fly) +7.48%
Nov-24-25 06:30AM	Tullow Oil moves forward on Ghana licence extensions and gas agreement (Offshore Technology)
Nov-11-25 09:06AM	Here are Tuesdays Top Wall Street Analyst Research Calls: Coreweave, Instacart, Qorvo, Robinhood Markets, Skyworks Solutions, Viasat and More (24/7 Wall St.)
Nov-03-25 06:02PM	Kosmos Energy Ltd (KOS) Q3 2025 Earnings Call Highlights: Strong Production Growth and ... (GuruFocus.com) -5.73%
05:10AM	Kosmos Energy: Q3 Earnings Snapshot (Associated Press Finance)
02:00AM	Kosmos Energy Announces Third Quarter 2025 Results (Business Wire)
01:46AM	Loading…
Oct-28-25 01:46AM	Kosmos Energy (KOS) - Among the Energy Stocks that Gained This Week (Insider Monkey)
Oct-15-25 07:16AM	Kosmos Energy Ltd. (KOS) Finishes Its Semi-Annual Assessment of Reserve-Based Lending Facilities (Insider Monkey)
Oct-07-25 02:00AM	Kosmos Energy to Host Third Quarter 2025 Results and Webcast on November 03, 2025 (Business Wire)
Oct-01-25 02:00AM	Kosmos Energy Provides Update on Financial Progress (Business Wire)
Sep-25-25 08:00AM	Kosmos Energy Enters Into Senior Secured Term Loan Facility With Shell for up to $250 Million (Business Wire)
Aug-25-25 07:44AM	3 Energy Stocks Under $5 With Strong Value Fundamentals (Zacks)
Aug-22-25 11:45PM	Bank of America Securities Lowers PT on Kosmos Energy (KOS), Maintains a Buy Rating (Insider Monkey) +5.75%
Aug-19-25 12:32AM	Kosmos Energy Ltd. (KOS) Reports Q2 2025 Results; Bank of America Reiterates 'Hold' Rating (Insider Monkey) -5.71%
Aug-05-25 02:30AM	Kosmos Posts $88 Million Q2 Loss Amid Ramp-Up of West Africa LNG Project (Oilprice.com)
Aug-04-25 05:07AM	Kosmos Energy: Q2 Earnings Snapshot (Associated Press Finance)
03:27AM	Kosmos Energy Q2 loss wider than expected, full-year outlook lowered (Investing.com)
02:00AM	Kosmos Energy Announces Second Quarter 2025 Results (Business Wire)
Jul-31-25 12:21AM	S&P Downgrades Kosmos Energy to 'CCC+' Amid Liquidity Strains and Refinancing Risks (Insider Monkey)
Jul-30-25 10:15AM	Kosmos Energy Ltd. (KOS) Fell Due to Market Concerns Amid OPEC+ Supply and Demand Fears (Insider Monkey) -5.17%
Jul-29-25 09:35AM	Kosmos Energy (KOS) Soars 7.7% Ahead of Q2 Earnings (Insider Monkey)
09:40AM	Loading…
Jul-21-25 09:40AM	Should Value Investors Buy Kosmos Energy (KOS) Stock? (Zacks)
Jul-18-25 08:05AM	Kosmos Energy (KOS) Fell Along with Broader Energy Prices (Insider Monkey)
Jul-17-25 12:55PM	Domestic Drillers Rush To Power AI Grid As Global Oil Demand Stays Unbroken (PR Newswire) +7.33%
Jul-08-25 02:00AM	Kosmos Energy to Host Second Quarter 2025 Results and Webcast on August 04, 2025 (Business Wire) +6.47%
Jul-07-25 09:10AM	Jefferies Maintains a Buy on Kosmos Energy (KOS) (Insider Monkey)
Jun-24-25 06:09AM	FLNG Gimi starts commercial operations at Greater Tortue Ahmeyim project (Offshore Technology)
Jun-23-25 06:49AM	Kosmos Energy Confirms Commercial Operations Date Reached for Golars FLNG Gimi at Greater Tortue Ahmeyim (Business Wire) -7.83%
Jun-13-25 03:32AM	Kosmos Energy (KOS): Among the Energy Stocks that Gained the Most This Week (Insider Monkey) +7.66%
Jun-04-25 02:00AM	The Government of Ghana, Tullow Oil, Kosmos Energy, PetroSA, GNPC and Explorco Sign Memorandum of Understanding to Extend Ghana Production Licenses to 2040 (Business Wire)
May-21-25 02:56AM	Why Did Kosmos Energy (KOS) Fall So Much This Week? (Insider Monkey)
May-19-25 11:04AM	Here's How the Short-Term Issues are Affecting Kosmos Energy Ltd.'s (KOS) (Insider Monkey)
May-15-25 03:47PM	Here is Why Kosmos Energy Ltd. (KOS) Surged So High This Week (Insider Monkey) -12.06%
May-07-25 03:18AM	Kosmos Energy Ltd (KOS) Q1 2025 Earnings Call Highlights: Strategic Cost Control and Production ... (GuruFocus.com)
02:06AM	Q1 2025 Kosmos Energy Ltd Earnings Call (Thomson Reuters StreetEvents)
May-06-25 05:07AM	Kosmos Energy: Q1 Earnings Snapshot (Associated Press Finance)
02:00AM	Kosmos Energy Announces First Quarter 2025 Results (Business Wire)
Apr-26-25 10:17AM	Is Kosmos Energy Ltd. (KOS) the Best Oil and Gas Penny Stock to Invest in Now? (Insider Monkey)
Apr-22-25 12:00PM	Patient Capital Management Q1 2025 Investment Review (Seeking Alpha)
Apr-17-25 02:54PM	BP, Kosmos Loads First LNG Export From GTA Phase 1, One of Africa's Deepest Gas Projects (Benzinga) +7.83%
02:31AM	Kosmos Energy Announces First LNG Cargo at the Greater Tortue Ahmeyim Project in Mauritania and Senegal (Business Wire)
Apr-07-25 02:00AM	Kosmos Energy to Host First Quarter 2025 Results and Webcast on May 6, 2025 (Business Wire) +12.50%
Apr-05-25 01:45PM	Why Kosmos Energy Ltd. (KOS) Stock Crashed This Week (Insider Monkey)
Mar-31-25 09:28AM	Should You Hold Kosmos Energy Ltd. (KOS)? (Insider Monkey)
Mar-26-25 02:14PM	Is Kosmos Energy Ltd. (KOS) the Best Fundamentally Strong Penny Stock to Buy Now? (InsiderMonkey)
Mar-25-25 05:42PM	Is Kosmos Energy Ltd. (NYSE:KOS) The Top Penny Stock That Will Skyrocket? (InsiderMonkey)
Mar-19-25 03:29AM	Is Kosmos Energy (KOS) One of the Most Oversold Penny Stocks to Buy According to Analysts? (Insider Monkey)
Mar-13-25 05:55PM	Why Kosmos Energy Ltd. (KOS) Is Losing This Week? (Insider Monkey)
Mar-08-25 09:14PM	Kosmos Energy Ltd. (KOS): Among the Best NYSE Penny Stocks to Buy According to Analysts (Insider Monkey)
Mar-05-25 06:30PM	Kosmos Energy Ltd. (KOS): Among the Best Value Penny Stocks to Invest In Now (Insider Monkey) -7.39%
Feb-27-25 11:05AM	Why Kosmos Energy (KOS) Is Losing this Week? (Insider Monkey) +5.28%
Feb-25-25 05:24AM	BP, Kosmos Greater Tortue Ahmeyim project prepares for first LNG shipment (Offshore Technology) -7.64%
02:02AM	Kosmos Energy Ltd (KOS) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... (GuruFocus.com)
01:57AM	Q4 2024 Kosmos Energy Ltd Earnings Call (Thomson Reuters StreetEvents)
Feb-24-25 06:07AM	Is Kosmos Energy Ltd. (KOS) the Best Get Rich Quick Stock to Invest In? (Insider Monkey) -9.43%
05:13AM	Kosmos Energy: Q4 Earnings Snapshot (Associated Press Finance)
03:37AM	BPs Greater Tortue Project Poised to Export First LNG Cargo (Bloomberg)
02:00AM	Kosmos Energy Announces Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-20-25 10:38AM	Is Kosmos Energy Ltd. (KOS) the Best Get Rich Fast Stock to Buy Now? (Insider Monkey)
Feb-10-25 11:05AM	Kosmos Energy achieves first LNG production at greater Tortue Ahmeyim project (Offshore Technology) +7.97%
02:00AM	Kosmos Energy Announces First LNG at the Greater Tortue Ahmeyim Project in Mauritania and Senegal (Business Wire)
Jan-22-25 07:08PM	Is Kosmos Energy (KOS) Among the Worst Performing Energy Stocks in 2024? (Insider Monkey)
Jan-20-25 09:59PM	Kosmos Energy Ltd. (KOS) Stock: An Under $5 Gem with Biggest Upside Potential (Insider Monkey)
Jan-13-25 02:00AM	Kosmos Energy to Host Fourth Quarter 2024 Results and Webcast on February 24, 2025 (Business Wire)
Jan-03-25 10:00AM	How to Navigate the Stock and Bond Markets in 2025 (The Wall Street Journal)
Jan-02-25 02:02AM	Kosmos Energy Announces First Gas at the Greater Tortue Ahmeyim LNG Project in Mauritania and Senegal (Business Wire) +8.77%
Dec-26-24 09:19AM	Kosmos (KOS) Stock was Pressured As Oil Prices Continued To Decline (Insider Monkey)
Dec-18-24 05:21AM	Kosmos Energy withdraws from Tullow Oil acquisition (Offshore Technology)
Dec-17-24 12:45PM	Form 8.3 - Kosmos Energy Ltd. (Business Wire) +19.19%
05:30AM	Kosmos Energy Statement Regarding Possible Offer for Tullow Oil plc (Business Wire)
Dec-12-24 03:04PM	Statement Regarding a Possible All-Share Offer for Tullow Oil plc by Kosmos Energy Ltd. (Business Wire) -15.09%
Nov-12-24 09:40AM	Are Investors Undervaluing Kosmos Energy (KOS) Right Now? (Zacks)
Nov-07-24 04:36AM	Senegal Expects First LNG Shipment Early Next Year (Bloomberg)
Nov-06-24 03:06PM	Is Kosmos Energy Ltd. (KOS) Positioned for Growth in the Oversold Energy Sector? (Insider Monkey)
12:51AM	Kosmos Energy Ltd. (KOS): Top Penny Stock with Growth Potential (Insider Monkey)
Nov-05-24 02:49AM	Q3 2024 Kosmos Energy Ltd Earnings Call (Thomson Reuters StreetEvents)
02:05AM	Kosmos Energy Ltd (KOS) Q3 2024 Earnings Call Highlights: Production Gains and Financial Resilience (GuruFocus.com)
Nov-04-24 05:02AM	Kosmos Energy: Q3 Earnings Snapshot (Associated Press Finance)
02:00AM	Kosmos Energy Announces Third Quarter 2024 Results (Business Wire)
Nov-03-24 12:14PM	Kosmos Energy Ltd. (KOS): Oversold Penny Stock To Invest In Now (Insider Monkey)
Oct-29-24 09:24AM	Kosmos Energy Ltd. (KOS): Oversold Small Cap Stock with Promising Growth Projects (Insider Monkey)
Oct-20-24 06:59PM	Is Kosmos Energy Ltd. (KOS) the Best Affordable Stock Under $10 to Buy? (Insider Monkey)
Oct-19-24 04:58PM	Kosmos Energy Ends Revolving Credit Facility Agreement (TipRanks)
Oct-18-24 08:02AM	Heres Why Patient Capital Management Saw Kosmos Energy (KOS) as a Classic Case Of Time Arbitrage (Insider Monkey)
Oct-16-24 07:16PM	Is Kosmos Energy Ltd. (KOS) the Most Promising Stock to Buy According to Wall Street Analysts? (Insider Monkey)
10:57AM	Is Kosmos Energy Ltd. (KOS) the Best High Growth Penny Stock That is Profitable in 2024? (Insider Monkey)
Oct-12-24 12:26PM	Is Kosmos Energy Ltd. (KOS) the Best Growth Stock Under $10 to Buy? (Insider Monkey)
Oct-09-24 07:34AM	BP wins arbitration against Kosmos for GTA LNG project (Offshore Technology)
Oct-08-24 12:50PM	Arbitration rules in favour of BP as sole buyer of Kosmos Energy's Senegal LNG project (Reuters)
Oct-03-24 02:00AM	Kosmos Energy to Host Third Quarter 2024 Results and Webcast on November 04, 2024 (Business Wire) +5.62%
Oct-01-24 11:00AM	Hedge Fund Interest in Kosmos Energy Ltd. (KOS) Stable at 25 Holders in Q2 2024 (Insider Monkey) +5.71%

Kosmos Energy Ltd. engages in the exploration, development, and production of oil and gas. The firm's assets include production offshore Ghana, Equatorial Guinea and the U.S. Gulf of Mexico, as well as a gas development offshore Mauritania and Senegal. It also maintains a sustainable exploration program balanced between proven basin infrastructure-led exploration, emerging basins, and frontier basins. The company was founded by Brian F. Maxted on April 23, 2003 and is headquartered in Dallas, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Glass Ronald W.	VP & Chief Accounting Officer	Feb 03 '26	Sale	1.37	19,285	26,420	342,945	Feb 05 05:13 PM
Glass Ronald W.	VP & Chief Accounting Officer	Feb 04 '26	Sale	1.42	3,313	4,704	339,632	Feb 05 05:13 PM
Marion Josh R.	SVP and General Counsel	Feb 03 '26	Sale	1.37	19,656	26,929	197,409	Feb 05 05:12 PM
Marion Josh R.	SVP and General Counsel	Feb 04 '26	Sale	1.42	3,284	4,663	194,125	Feb 05 05:12 PM
Shah Nealesh D.	SVP and CFO	Feb 03 '26	Sale	1.37	54,434	74,575	1,729,857	Feb 05 05:12 PM
Shah Nealesh D.	SVP and CFO	Feb 04 '26	Sale	1.42	24,690	35,060	1,705,167	Feb 05 05:12 PM
INGLIS ANDREW G	Chairman and CEO	Feb 03 '26	Sale	1.37	103,554	141,869	4,271,645	Feb 05 05:10 PM
INGLIS ANDREW G	Chairman and CEO	Feb 04 '26	Sale	1.42	44,628	63,372	4,227,017	Feb 05 05:10 PM
INGLIS ANDREW G	Officer	Feb 04 '26	Proposed Sale	1.42	44,628	63,452		Feb 04 03:27 PM
Shah Nealesh D.	Officer	Feb 04 '26	Proposed Sale	1.42	24,690	35,104		Feb 04 03:26 PM
Marion Josh R.	Officer	Feb 04 '26	Proposed Sale	1.42	3,284	4,669		Feb 04 03:16 PM
Glass Ronald W.	Officer	Feb 04 '26	Proposed Sale	1.42	3,313	4,710		Feb 04 03:08 PM
Marion Josh R.	Officer	Feb 03 '26	Proposed Sale	1.38	19,656	27,060		Feb 03 04:52 PM
Shah Nealesh D.	Officer	Feb 03 '26	Proposed Sale	1.38	54,434	74,939		Feb 03 04:34 PM
INGLIS ANDREW G	Officer	Feb 03 '26	Proposed Sale	1.38	103,554	142,563		Feb 03 04:27 PM
Glass Ronald W.	Officer	Feb 03 '26	Proposed Sale	1.38	19,285	26,550		Feb 03 04:21 PM
Christopher James Ball	Former Officer	Dec 18 '25	Proposed Sale	0.99	1,430,084	1,420,931		Dec 22 04:28 PM
Christopher James Ball	Former Officer	Dec 17 '25	Proposed Sale	0.92	7,787	7,163		Dec 18 04:33 PM
Grant John Douglas Kelso	Director	Jun 05 '25	Sale	1.81	27,923	50,541	29,921	Jun 06 04:53 PM
Grant John Douglas Kelso	Director	Jun 05 '25	Proposed Sale	1.81	27,923	50,541		Jun 05 10:02 AM

CX

Cemex S.A.B. De C.V. ADR

DYN

Dyne Therapeutics Inc

KOS

Kosmos Energy Ltd

Upgrade your FINVIZ experience